Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Routinely accessible parameters of mineralocorticoid receptor function, depression subtypes and response prediction: a post-hoc analysis from the early medication change trial in major depressive disorder.
Engelmann J, Murck H, Wagner S, Zillich L, Streit F, Herzog DP, Braus DF, Tadic A, Lieb K, Műller MB. Engelmann J, et al. Among authors: braus df. World J Biol Psychiatry. 2022 Oct;23(8):631-642. doi: 10.1080/15622975.2021.2020334. Epub 2022 Jan 25. World J Biol Psychiatry. 2022. PMID: 34985381
Plasma brain-derived neurotrophic factor (pBDNF) and executive dysfunctions in patients with major depressive disorder.
Wagner S, Kayser S, Engelmann J, Schlicht KF, Dreimüller N, Tüscher O, Müller-Dahlhaus F, Braus DF, Tadić A, Neyazi A, Frieling H, Lieb K. Wagner S, et al. Among authors: braus df. World J Biol Psychiatry. 2019 Sep;20(7):519-530. doi: 10.1080/15622975.2018.1425478. Epub 2018 Feb 2. World J Biol Psychiatry. 2019. PMID: 29334322 Clinical Trial.
Higher BDNF plasma levels are associated with a normalization of memory dysfunctions during an antidepressant treatment.
Engelmann J, Wagner S, Wollschläger D, Kaaden S, Schlicht KF, Dreimüller N, Braus DF, Müller MB, Tüscher O, Frieling H, Tadić A, Lieb K. Engelmann J, et al. Among authors: braus df. Eur Arch Psychiatry Clin Neurosci. 2020 Mar;270(2):183-193. doi: 10.1007/s00406-019-01006-z. Epub 2019 Mar 30. Eur Arch Psychiatry Clin Neurosci. 2020. PMID: 30929060
Epigenetic signatures in antidepressant treatment response: a methylome-wide association study in the EMC trial.
Engelmann J, Zillich L, Frank J, Wagner S, Cetin M, Herzog DP, Müller MB, Tadic A, Foo JC, Sirignano L, Braus DF, Dahmen N, Sordon S, Riemenschneider M, Spaniol C, Gasparoni G, Rietschel M, Witt SH, Lieb K, Streit F. Engelmann J, et al. Among authors: braus df. Transl Psychiatry. 2022 Jul 7;12(1):268. doi: 10.1038/s41398-022-02032-7. Transl Psychiatry. 2022. PMID: 35794104 Free PMC article. Clinical Trial.
Rationale and design of the randomised clinical trial comparing early medication change (EMC) strategy with treatment as usual (TAU) in patients with major depressive disorder--the EMC trial.
Tadić A, Gorbulev S, Dahmen N, Hiemke C, Braus DF, Röschke J, van Calker D, Wachtlin D, Kronfeld K, Gorbauch T, Seibert-Grafe M, Lieb K; EMC Study Group. Tadić A, et al. Among authors: braus df. Trials. 2010 Feb 26;11:21. doi: 10.1186/1745-6215-11-21. Trials. 2010. PMID: 20187947 Free PMC article. Clinical Trial.
Randomized controlled study of early medication change for non-improvers to antidepressant therapy in major depression--The EMC trial.
Tadić A, Wachtlin D, Berger M, Braus DF, van Calker D, Dahmen N, Dreimüller N, Engel A, Gorbulev S, Helmreich I, Kaiser AK, Kronfeld K, Schlicht KF, Tüscher O, Wagner S, Hiemke C, Lieb K. Tadić A, et al. Among authors: braus df. Eur Neuropsychopharmacol. 2016 Apr;26(4):705-16. doi: 10.1016/j.euroneuro.2016.02.003. Epub 2016 Feb 9. Eur Neuropsychopharmacol. 2016. PMID: 26899588 Clinical Trial.
124 results